Arthritis

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA ALERT
joint pain
FDA ALERT
FDA Approves First Biosimilar to Tocilizumab to Treat Adults, Pediatric Patients With Arthritis
11/15/2023

Jessica Ganga

Jessica Ganga
In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.
11/15/2023
Arthritis
Arthritis
FDA Approves Treatment Option for Polyarticular Course JIA
10/01/2020
A Janus kinase inhibitor was approved for the treatment of active polyarticular course juvenile idiopathic arthritis among patients aged 2 years or older.
10/01/2020
Arthritis
Arthritis
FDA: New Option for Psoriatic Arthritis Approved
12/15/2017
The US Food and Drug Administration recently approved a drug for the treatment of adults with active psoriatic arthritis.
12/15/2017